This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MILTON M. CONNELL, MD; BROOKS J. POLEY, MD; JOE R. McFARLANE, MD

Arch Ophthalmol. 1964;71(6):816-821.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

This paper reports a patient with pigmentary chorioretinopathy which developed shortly after cessation of treatment with thioridazine, a drug of the phenothiazine group. The reaction occurred at a dosage level lower than had been reported previously and was accompanied by relative central scotomas which contained a more dense ringtype defect.

In 1960, Potts¹ demonstrated high concentrations of phenothiazine derivatives in choroidal tissue and specifically studied the adsorption of these compounds on the individual pigment granules. Hence, the term "chorioretinopathy" seems appropriate.

Report of Case

A 37-year-old Negro woman was admitted to the Philadelphia General Hospital in November, 1962, because of an acute schizophrenic reaction. She received thioridazine for 40 days. The dosage level was increased until a daily maximum of 1,200 mg and a total of 40 gm was administered. The patient also received 25 mg of imipramine four times daily. Benztropine methanesulfonate, 5 mg per day, was given . . . [Full Text PDF of this Article]

Author Affiliations
Philadelphia

From the Department of Ophthalmology, Hospital of the University of Pennsylvania, Philadelphia General Hospital, Veterans Administration Hospital, and the Children's Hospital of Philadelphia.

Footnotes
Presented at the College of Physicians of Philadelphia on April 18, 1963.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?